S A Renowden Selected Research

Vanishing White Matter Leukodystrophy with Ovarian Failure

12/2016

Ovarioleukodystrophy due to EIF2B5 mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S A Renowden Research Topics

Disease

2	Stroke (Strokes) 01/2016 - 07/2012
2	Intracranial Aneurysm (Cerebral Aneurysm) 02/2009 - 08/2008
2	Aneurysm (Aneurysms) 02/2009 - 08/2008
1	Leukoencephalopathies 12/2016
1	Epilepsy (Aura) 12/2016
1	Status Epilepticus (Complex Partial Status Epilepticus) 12/2016
1	Primary Ovarian Insufficiency 12/2016
1	Vanishing White Matter Leukodystrophy with Ovarian Failure 12/2016
1	Thrombosis (Thrombus) 01/2016
1	Infarction (Infarctions) 07/2012
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 05/2012
1	Pain (Aches) 12/2005

Drug/Important Bio-Agent (IBA)

1	Peptide Initiation Factors (Initiation Factor)IBA 12/2016
1	SteroidsIBA 05/2012

Therapy/Procedure

3	Therapeutics 01/2016 - 08/2008
2	Retreatment 02/2009 - 08/2008
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 12/2016
1	Stents 01/2016
1	Thrombectomy 01/2016
1	Rhizotomy 12/2005